Literature DB >> 21122322

[Expression of regulatory T cells and Th17 cells in idiopathic thrombocytopenic purpura and its significance].

Ning-Hong Guo1, Qing-Zhi Shi, Jian-Yuan Hua, Zhen-Jiang Li, Jian Li, Wen-Feng He, Qiong Wu.   

Abstract

OBJECTIVE: To investigate the expression of regulatory T cells and Th17 cells in idiopathic thrombocytopenic purpura (ITP) and its significance.
METHODS: The quantity of CD4(+)CD25(+)T cells, CD4(+)CD25(high) T cells and CD4(+) IL-17(+)T cells in peripheral blood were measured with flow cytometry (FCM), the plasma level of IL-10 and IL-17 with ELISA and the expression of Foxp3 mRNA and RORc mRNA with RT-PCR in 29 newly diagnosed ITP patients and 28 healthy controls.
RESULTS: The ratio of CD4(+)CD25(+)T cells/CD4(+) T cells in the peripheral blood of ITP patients was significantly higher than that of the normal controls (P < 0.05). And the ratio of CD4(+)CD25(high) T/CD4(+) T cells in the patients was remarkably lower (P < 0.05). There was no difference in the percentage of CD4(+) IL-17(+)T/CD4(+) T cells between ITP patients and controls (P > 0.05). The ratio of Treg/Th17 was lower in ITP patients (P < 0.05). The plasma level of IL-10 in ITP patients was significantly decreased (P < 0.05), whereas no statistical difference was observed in the level of IL-17 (P > 0.05). The Foxp3 mRNA expression levels were largely reduced (P < 0.05), but the RORc mRNA expression was increased compared with that in controls (P < 0.05).
CONCLUSION: The imbalance of Treg/Th17 plays an important role in the pathogenesis of ITP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21122322

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  4 in total

1.  Analysis of clinical effects and mechanism of recombinant human interleukin-11 with glucocorticoids for treatment of idiopathic thrombocytopenic purpura.

Authors:  Xifeng Wu; Lijuan Wang; Lin Sun; Tantan Li; Xuehong Ran
Journal:  Exp Ther Med       Date:  2016-12-21       Impact factor: 2.447

Review 2.  Pathogenesis and Therapeutic Mechanisms in  Immune Thrombocytopenia (ITP).

Authors:  Anne Zufferey; Rick Kapur; John W Semple
Journal:  J Clin Med       Date:  2017-02-09       Impact factor: 4.241

3.  Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study.

Authors:  Jae-Myeong Lee; Hyo-Jo Han; Won-Kyu Choi; Subin Yoo; Soojin Baek; Jaemin Lee
Journal:  BMC Anesthesiol       Date:  2018-11-08       Impact factor: 2.217

Review 4.  Effects of Dexmedetomidine on Immune Cells: A Narrative Review.

Authors:  Rui Chen; Yan Sun; Jing Lv; Xiaoke Dou; Maosha Dai; Shujun Sun; Yun Lin
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.